Skip to content

Clinical trials

Schizophrenia trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Finland Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20052
20073
20084
20092
20102
20112
20131
20142
20161
20181
20191
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status5
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Niuvanniemi Hospital3
Boehringer Ingelheim2
H. Lundbeck A/S2
Hoffmann-La Roche2
Jesper Ekelund2
Eli Lilly and Company1
Helsinki University Central Hospital1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia30
Psychotic Disorders9
Bipolar Disorder1
Body Weight Changes1
Bronchiolitis Obliterans Syndrome1
Ketosis1
Neurobehavioral Manifestations1
Schizophrenia, Paranoid1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.